| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
25,261 |
17,732 |
$4.09M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,324 |
15,121 |
$803K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
725 |
696 |
$34K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
524 |
508 |
$25K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
346 |
336 |
$16K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
94 |
80 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
38 |
37 |
$2K |
| 90658 |
|
92 |
92 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
43 |
42 |
$1K |
| 0001A |
|
44 |
43 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
568 |
520 |
$627.43 |
| 0002A |
|
17 |
16 |
$560.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,777 |
2,646 |
$393.98 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
12 |
12 |
$270.08 |
| 0071A |
|
19 |
19 |
$200.00 |
| 92552 |
|
2,822 |
2,724 |
$6.33 |
| 87428 |
|
338 |
326 |
$0.29 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
208 |
204 |
$0.28 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
128 |
120 |
$0.05 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
700 |
659 |
$0.01 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
59 |
59 |
$0.01 |
| 1160F |
|
16,548 |
13,644 |
$0.00 |
| 1159F |
|
16,912 |
13,927 |
$0.00 |
| 99173 |
|
2,976 |
2,851 |
$0.00 |
| 3028F |
|
1,009 |
874 |
$0.00 |
| 3078F |
|
69 |
51 |
$0.00 |
| 90670 |
|
40 |
36 |
$0.00 |
| S5000 |
Prescription drug, generic |
49 |
48 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$0.00 |
| 1033F |
|
96 |
67 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
24 |
23 |
$0.00 |
| 1003F |
|
14 |
12 |
$0.00 |
| 90686 |
|
662 |
648 |
$0.00 |
| 1126F |
|
697 |
646 |
$0.00 |
| 2010F |
|
9,781 |
8,252 |
$0.00 |
| 2001F |
|
11,680 |
9,674 |
$0.00 |
| 3008F |
|
15,736 |
13,013 |
$0.00 |
| 1170F |
|
267 |
217 |
$0.00 |
| 2000F |
|
399 |
320 |
$0.00 |
| 1220F |
|
1,895 |
1,687 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
284 |
274 |
$0.00 |
| 3037F |
|
86 |
77 |
$0.00 |
| 87807 |
|
12 |
12 |
$0.00 |
| 3074F |
|
187 |
144 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
728 |
675 |
$0.00 |
| 90688 |
|
304 |
294 |
$0.00 |
| 1000F |
|
34 |
29 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
16 |
14 |
$0.00 |
| 1036F |
|
14 |
14 |
$0.00 |
| 90651 |
|
13 |
13 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
16 |
14 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
14 |
$0.00 |